Can patients with fibromyalgia be improved by subcutaneous injections of sterile water in tenderpoints? A randomised, controlled, tripple masked clinical trial
- Conditions
- Fibromyalgia
- Registration Number
- EUCTR2005-000654-67-SE
- Lead Sponsor
- ppsala University/Uppsala County Council
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Authorised-recruitment may be ongoing or finished
- Sex
- Female
- Target Recruitment
- 60
Inclusion Criteria
Women, less than 65 years old, non-pregnant, non-brest feeding
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
Symptoms or signs of rheumatoid arthritis, multiple sclerosis, malignancy, or other serious disease
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Main Objective: To test the hypothesis that injections of sterile water in the tenderpoints relieves the pain symptoms during at least one year;Secondary Objective: The pain relief is caused by a resetting of the nosoceptors, in turn caused by changes in the release of neuropeptides;Primary end point(s): Number of tenderpoints, arm abduction test, chair raising test, and a set of quality of life measures
- Secondary Outcome Measures
Name Time Method